Piotr Stępnicki

886 total citations · 1 hit paper
18 papers, 593 citations indexed

About

Piotr Stępnicki is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Piotr Stępnicki has authored 18 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 6 papers in Organic Chemistry. Recurrent topics in Piotr Stępnicki's work include Receptor Mechanisms and Signaling (10 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Piotr Stępnicki is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Piotr Stępnicki collaborates with scholars based in Finland, Poland and Spain. Piotr Stępnicki's co-authors include Agnieszka A. Kaczor, Magda Kondej, Dariusz Matosiuk, Marián Castro, Tomasz M. Wróbel, Ewa Kędzierska, Piotr Wójcik, Agata Bartyzel, Grażyna Biała and Marı́a Isabel Loza and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Piotr Stępnicki

18 papers receiving 582 citations

Hit Papers

Current Concepts and Treatments of Schizophrenia 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Piotr Stępnicki Finland 9 226 174 163 113 70 18 593
Magda Kondej Poland 6 199 0.9× 158 0.9× 157 1.0× 102 0.9× 58 0.8× 10 515
Zsolt Némethy Hungary 10 263 1.2× 265 1.5× 229 1.4× 37 0.3× 100 1.4× 20 638
Athanasios Metaxas Denmark 17 314 1.4× 263 1.5× 44 0.3× 93 0.8× 98 1.4× 40 723
Debbi Ann Morrissette United States 11 150 0.7× 172 1.0× 273 1.7× 65 0.6× 139 2.0× 23 704
Daniela Alberati Switzerland 16 358 1.6× 456 2.6× 121 0.7× 132 1.2× 51 0.7× 30 806
Jonathan J. Sabbagh United States 20 612 2.7× 256 1.5× 50 0.3× 98 0.9× 112 1.6× 31 1.3k
Cornelia Dorner‐Ciossek Germany 19 412 1.8× 220 1.3× 64 0.4× 70 0.6× 205 2.9× 41 817
Michael A. Ackley United States 13 287 1.3× 401 2.3× 89 0.5× 100 0.9× 97 1.4× 22 859
Burbaeva GSh Russia 14 244 1.1× 227 1.3× 119 0.7× 200 1.8× 41 0.6× 83 695
Erin M. MacKenzie Canada 12 122 0.5× 108 0.6× 47 0.3× 83 0.7× 90 1.3× 26 411

Countries citing papers authored by Piotr Stępnicki

Since Specialization
Citations

This map shows the geographic impact of Piotr Stępnicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Stępnicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Stępnicki more than expected).

Fields of papers citing papers by Piotr Stępnicki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piotr Stępnicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Stępnicki. The network helps show where Piotr Stępnicki may publish in the future.

Co-authorship network of co-authors of Piotr Stępnicki

This figure shows the co-authorship network connecting the top 25 collaborators of Piotr Stępnicki. A scholar is included among the top collaborators of Piotr Stępnicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piotr Stępnicki. Piotr Stępnicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Stępnicki, Piotr, Dariusz Matosiuk, Tomasz M. Wróbel, et al.. (2024). Discovery and in vitro Evaluation of Novel Serotonin 5‐HT2A Receptor Ligands Identified Through Virtual Screening. ChemMedChem. 19(14). e202400080–e202400080. 2 indexed citations
2.
Stępnicki, Piotr, et al.. (2024). Thermal behavior and determination of physicochemical properties of novel candidates for antipsychotic drugs. Journal of Thermal Analysis and Calorimetry. 149(17). 9315–9332. 1 indexed citations
3.
Stępnicki, Piotr, Sylwia Wośko, Agata Bartyzel, et al.. (2023). Development and Characterization of Novel Selective, Non-Basic Dopamine D2 Receptor Antagonists for the Treatment of Schizophrenia. Molecules. 28(10). 4211–4211. 1 indexed citations
4.
Wójcik, Piotr, et al.. (2023). Effects of small molecules on neurogenesis: Neuronal proliferation and differentiation. Acta Pharmaceutica Sinica B. 14(1). 20–37. 13 indexed citations
5.
Stępnicki, Piotr, Katarzyna M. Targowska‐Duda, Agata Bartyzel, et al.. (2023). Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds–synthesis, biological activity, and structural evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2209828–2209828. 5 indexed citations
6.
Kędzierska, Ewa, Katarzyna M. Targowska‐Duda, Tomasz M. Wróbel, et al.. (2022). Funnel metadynamics and behavioral studies reveal complex effect of D2AAK1 ligand on anxiety-like processes. Scientific Reports. 12(1). 21192–21192. 1 indexed citations
7.
Kondej, Magda, Tomasz M. Wróbel, Katarzyna M. Targowska‐Duda, et al.. (2022). Multitarget Derivatives of D2AAK1 as Potential Antipsychotics: The Effect of Substitution in the Indole Moiety. ChemMedChem. 17(15). e202200238–e202200238. 5 indexed citations
8.
Stępnicki, Piotr, et al.. (2022). What are the challenges with multi-targeted drug design for complex diseases?. Expert Opinion on Drug Discovery. 17(7). 673–683. 26 indexed citations
10.
Kaczor, Agnieszka A., Katarzyna M. Targowska‐Duda, Piotr Stępnicki, et al.. (2021). N-(3-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}propyl)-1H-indazole-3-carboxamide (D2AAK3) as a potential antipsychotic: In vitro, in silico and in vivo evaluation of a multi-target ligand. Neurochemistry International. 146. 105016–105016. 11 indexed citations
11.
Stępnicki, Piotr, et al.. (2021). Overcoming Depression with 5-HT2A Receptor Ligands. International Journal of Molecular Sciences. 23(1). 10–10. 27 indexed citations
12.
Bartyzel, Agata, Magda Kondej, Piotr Stępnicki, Tomasz M. Wróbel, & Agnieszka A. Kaczor. (2021). Experimental and computational structural studies of 5-substituted-3-(1-arylmethyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles. Journal of Molecular Structure. 1245. 130998–130998. 2 indexed citations
13.
Stępnicki, Piotr, et al.. (2021). Current Approaches and Tools Used in Drug Development against Parkinson’s Disease. Biomolecules. 11(6). 897–897. 14 indexed citations
14.
Stępnicki, Piotr, et al.. (2020). Multi-targeted drug design strategies for the treatment of schizophrenia. Expert Opinion on Drug Discovery. 16(1). 101–114. 16 indexed citations
15.
Sołek, Przemysław, Ewa Kędzierska, Tomasz M. Wróbel, et al.. (2020). The Antipsychotic D2AAK1 as a Memory Enhancer for Treatment of Mental and Neurodegenerative Diseases. International Journal of Molecular Sciences. 21(22). 8849–8849. 4 indexed citations
16.
Kondej, Magda, Tomasz M. Wróbel, Piotr Stępnicki, et al.. (2019). Synthesis, pharmacological and structural studies of 5-substituted-3-(1-arylmethyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as multi-target ligands of aminergic GPCRs. European Journal of Medicinal Chemistry. 180. 673–689. 19 indexed citations
17.
Stępnicki, Piotr, Magda Kondej, & Agnieszka A. Kaczor. (2018). Current Concepts and Treatments of Schizophrenia. Molecules. 23(8). 2087–2087. 380 indexed citations breakdown →
18.
Kondej, Magda, Piotr Stępnicki, & Agnieszka A. Kaczor. (2018). Multi-Target Approach for Drug Discovery against Schizophrenia. International Journal of Molecular Sciences. 19(10). 3105–3105. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026